Seed · 2026-10-26 · Healthcare
DropGenie raises $5.0M
58
AI Score
Amount
$5.0M
Round
Seed
Lead
Skeleton Key
HQ
Montréal, CA
Why it matters: The round shows how a lab-automation startup positions miniaturized CRISPR screening as a data supplier for AI drug-discovery models, with named pharma partners and a launch planned for next year.
DropGenie, a Montreal and Boston biotech startup, closed a $5 million USD seed-plus round after BDC Capital's Thrive Fund joined.
- Participants:
- BDC Capital's Thrive Fund, Merck Global Health Innovation Fund, CQDM, Real Ventures, Anges Québec
- Source:
- BetaKit ↗ · Midu summary
Deal Dossier PRO
Pro feature
Deal Dossier for DropGenie
Company, lead and participating investors, founders, and verified public contact channels — sourced, generated on demand.
Generate dossier — ProFigures marked company-reported are unaudited. Not investment advice. Request a correction or removal (team@midu.si).
Recent Healthcare rounds
Subscribe to the newsletters
Free, by email. No account needed. Pick one or both.
No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.
Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing